A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers

Annals of Pharmacotherapy

Volumn 34, Issue 3, 2000, Pages 295-299

  Chen, Connie ^a   Danekas, Lynne H ^a   Ratko, Thomas A ^a   Vlasses, Peter H ^a   Matuszewski, Karl A ^a  

^a University HealthSystem Consortium   (United States)

Author keywords

Guidelines; Intravenous immunoglobulin; Off label use

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; BACKACHE; CHILL; CLINICAL TRIAL; DRUG INDICATION; DRUG LABELING; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; DATA COLLECTION; DRUG UTILIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; TREATMENT OUTCOME; UNITED STATES;

EID: 0034009676     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19252     Document Type: Article

References (6)

1. Epstein J, Zoon K. FDA IVIG information transmission. Available from: www.fad.gov/cber/letters.htm. Accessed February 4, 1998.
2. Ratko T. Technology assessment: intravenous immunoglobulin preparations. Oak Brook, IL: University HealthSystem Consortium, April 1995.
3. Ratko T, Burnett D, Foulke G, Matuszewski K, Sacher R, the University Hospital Consortium Expert Panel for Off-label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations. Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995;273:1865-70.
4. Ratko T. Technology assessment: intravenous immunoglobulin preparations. Oak Brook, IL: University HealthSystem Consortium, March 1999.
5. 1999 Drug topics red book. Montvale, NJ: Medical Economics, 1999.
6. IGIV trials should focus on infections, use non-inferiority design -FDA. FDC Rep Pink Sheet 1999;61(14):5.